Shendelman Shoshana 4
4 · Applied Therapeutics Inc. · Filed Oct 13, 2022
Insider Transaction Report
Form 4
Shendelman Shoshana
DirectorPresident and CEO10% Owner
Transactions
- Purchase
Common Stock
2022-10-13$0.56/sh+73,256$40,891→ 717,495 total
Holdings
- 1,492,094(indirect: See footnote)
Common Stock
- 290,280(indirect: See footnote)
Common Stock
- 709,720(indirect: See footnote)
Common Stock
- 88,397(indirect: See footnote)
Common Stock
- 1,750,000(indirect: See footnote)
Common Stock
Footnotes (7)
- [F1]These shares were purchased by Dr. Shendelman in multiple transactions.
- [F2]Weighted average price. These shares were purchased by Dr. Shendelman in multiple transactions at prices ranging from $0.512 to $0.5768 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F3]Through a grantor retained annuity trust.
- [F4]Through a family trust controlled by the reporting person's spouse.
- [F5]Through the reporting person's spouse.
- [F6]Through a family trust controlled by the reporting person.
- [F7]Through Clearpoint Strategy Group LLC of which the reporting person is the sole owner.